DELSTRIGO
Identification of Delstrigo
No description |
Google image searchProduct monograph
Active ingredients
doravirine, 100 MG
lamivudine, 300 MG
tenofovir disoproxil fumarate, 300 MG
DIN: 02482592
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: MERCK CANADA INC
Date: 10-DEC-2018
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR24 — LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE (ATC/DDD)
Reference brand drug: Delstrigo
External Links for Delstrigo
Search on Google
- Delstrigo side effects
- Delstrigo dosage
- doravirine side effects
- doravirine dosage
- lamivudine side effects
- lamivudine dosage
- tenofovir disoproxil fumarate side effects
- tenofovir disoproxil fumarate dosage
Merck Canada Inc
Go to Merck website to see drug product details. Sometimes you can find delstrigo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.